SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 184 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $242,188 | -10.5% | 403,782 | +94.1% | 0.00% | -50.0% |
| Q2 2023 | $270,462 | -70.6% | 208,048 | -60.1% | 0.00% | -66.7% |
| Q1 2023 | $918,704 | +149.0% | 521,991 | +344.2% | 0.01% | +200.0% |
| Q4 2022 | $369,026 | -42.0% | 117,524 | -9.4% | 0.00% | -60.0% |
| Q3 2022 | $636,000 | +55.1% | 129,789 | +31.1% | 0.01% | +66.7% |
| Q2 2022 | $410,000 | -38.3% | 99,010 | +144.2% | 0.00% | -75.0% |
| Q4 2017 | $665,000 | +41.5% | 40,540 | +29.4% | 0.01% | +33.3% |
| Q3 2017 | $470,000 | – | 31,340 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |